1. Home
  2. COCP vs MULN Comparison

COCP vs MULN Comparison

Compare COCP & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • MULN
  • Stock Information
  • Founded
  • COCP N/A
  • MULN 2014
  • Country
  • COCP United States
  • MULN United States
  • Employees
  • COCP N/A
  • MULN N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • MULN Auto Manufacturing
  • Sector
  • COCP Health Care
  • MULN Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • MULN Nasdaq
  • Market Cap
  • COCP 18.3M
  • MULN 15.1M
  • IPO Year
  • COCP N/A
  • MULN N/A
  • Fundamental
  • Price
  • COCP $1.99
  • MULN $1.32
  • Analyst Decision
  • COCP Strong Buy
  • MULN
  • Analyst Count
  • COCP 1
  • MULN 0
  • Target Price
  • COCP $7.00
  • MULN N/A
  • AVG Volume (30 Days)
  • COCP 14.9K
  • MULN 2.1M
  • Earning Date
  • COCP 11-13-2024
  • MULN 02-11-2025
  • Dividend Yield
  • COCP N/A
  • MULN N/A
  • EPS Growth
  • COCP N/A
  • MULN N/A
  • EPS
  • COCP N/A
  • MULN N/A
  • Revenue
  • COCP N/A
  • MULN $156,570.00
  • Revenue This Year
  • COCP N/A
  • MULN N/A
  • Revenue Next Year
  • COCP N/A
  • MULN N/A
  • P/E Ratio
  • COCP N/A
  • MULN N/A
  • Revenue Growth
  • COCP N/A
  • MULN N/A
  • 52 Week Low
  • COCP $1.33
  • MULN $1.21
  • 52 Week High
  • COCP $3.10
  • MULN $1,870.00
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.27
  • MULN 29.41
  • Support Level
  • COCP $1.83
  • MULN $2.11
  • Resistance Level
  • COCP $2.07
  • MULN $1.93
  • Average True Range (ATR)
  • COCP 0.11
  • MULN 0.23
  • MACD
  • COCP -0.01
  • MULN -0.01
  • Stochastic Oscillator
  • COCP 44.74
  • MULN 6.75

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About MULN Mullen Automotive Inc.

Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.

Share on Social Networks: